| 股票代码：600272 | 股票简称：开开实业 | | | 编号：2025—056 | | --- | --- | --- | --- | --- | | 900943 | | 开开 | B 股 | | 上海开开实业股份有限公司 单位：万元 | 序 | 受托方名称 | 产品类型 | 实际投入金 | 实际支取 | 现金管理 | 尚未支取 | | --- | --- | --- | --- | --- | --- | --- | | 号 | | | 额 | 本金 | 收益 | 本金 | | 1 | 上海银行股份有限 | | | 3,500.00 | 1.74 | 12,049.00 | | | 公司南西支行 | 通 知 存 款 | 15,549.00 | | | | | 2 | | | | 3,300.00 | 3.97 | 8,749.00 | | | 合 计 | | 15,549.00 | 6,800.00 | 5.71 | 8,749.00 | | | 现金管理额度上限 | | | | | 15,549.00 | | | 当前现金管理金额 | | | | | 8,749.00 | 截至本公告披露日，公司 ...

Market Overview - The pharmaceutical commercial sector experienced a decline of 0.29% on September 10, with Dazhenglin leading the drop [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] Stock Performance - Key stocks in the pharmaceutical commercial sector showed varied performance, with Seer Medical (603716) rising by 3.99% to a closing price of 28.70, and Dazhenglin (603233) falling by 2.37% to 17.30 [1][2] - Other notable gainers included Guofa Co. (600538) with a 1.65% increase and Dazhangzhang (002462) with a 1.22% increase [1] Trading Volume and Value - Seer Medical had a trading volume of 250,500 shares and a transaction value of 719 million yuan, while Dazhenglin had a trading volume of 77,200 shares and a transaction value of 134 million yuan [1][2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 11.87 million yuan from institutional investors and 50.86 million yuan from speculative funds, while retail investors contributed a net inflow of 62.74 million yuan [2] - Specific stocks like Seer Medical and Jiuzhoutong (600998) had significant net inflows from institutional investors, while others like Yifeng Pharmacy (603939) experienced net outflows from both institutional and speculative funds [3]

Market Overview - As of 10:29 AM today, the Shanghai Composite Index stands at 3864.71 points, above the annual line, with a change of 0.18% [1] - The total trading volume of A-shares today is 138.21 billion yuan [1] Stocks Breaking Annual Line - A total of 41 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Energy Iron Han (节能铁汉) with a deviation rate of 14.24% and a daily increase of 14.69% [1] - Qidi Environment (启迪环境) with a deviation rate of 7.10% and a daily increase of 10.26% [1] - ST Quanwei (ST泉为) with a deviation rate of 6.60% and a daily increase of 9.06% [1] Detailed Stock Performance - The following table summarizes the performance of selected stocks that have recently broken the annual line: | Stock Code | Stock Name | Daily Change (%) | Turnover Rate (%) | Annual Line (yuan) | Latest Price (yuan) | Deviation Rate (%) | | --- | --- | --- | --- | --- | --- | --- | | 300197 | 节能铁汉 | 14.69 | 5.66 | 2.12 | 2.42 | 14.24 | | 000826 | 启迪环境 | 10.26 | 8.19 | 2.01 | 2.15 | 7.10 | | 300716 | ST泉为 | 9.06 | 3.95 | 10.05 | 10.71 | 6.60 | | 001215 | 千味央厨 | 3.57 | 2.39 | 29.19 | 30.19 | 3.43 | | 601882 | 海天精工 | 5.10 | 1.67 | 20.52 | 21.02 | 2.45 | | 601298 | 青岛港 | 2.59 | 0.45 | 8.54 | 8.72 | 2.09 | | 002771 | 真视通 | 3.22 | 3.18 | 17.64 | 17.97 | 1.85 | | 600653 | 申华控股 | 2.56 | 1.44 | 1.97 | 2.00 | 1.76 | | 300141 | 和顺电气 | 1.77 | 1.04 | 9.07 | 9.22 | 1.63 | | 002390 | 信邦制药 | 2.75 | 1.17 | 3.68 | 3.73 | 1.46 | | 600189 | 泉阳泉 | 1.49 | 1.23 | 7.38 | 7.48 | 1.41 | | 601328 | 交通银行 | 1.51 | 0.53 | 7.28 | 7.38 | 1.40 | | 600518 | 康美药业 | 4.41 | 2.72 | 2.10 | 2.13 | 1.25 | | 300318 | 博晖创新 | 1.18 | 0.45 | 5.92 | 5.98 | 1.08 | | 300144 | 宋城演艺 | 1.49 | 1.35 | 8.82 | 8.88 | 0.72 | | 600916 | 中国黄金 | 1.83 | 2.15 | 8.27 | 8.33 | 0.71 | | 300067 | 安诺其 | 1.48 | 1.87 | 5.44 | 5.47 | 0.61 | | 600272 | 开开实业 | 1.36 | 1.09 | 13.39 | 13.45 | 0.48 | | 603310 | 巍华新材 | 0.61 | 0.69 | 17.96 | 18.05 | 0.47 | | 603718 | 海利生物 | 0.70 | 0.66 | 7.17 | 7.20 | 0.41 | | 603768 | 常青股份 | 0.95 | 0.80 | 12.72 | 12.76 | 0.35 | | 600062 | 华润双鹤 | 1.08 | 0.71 | 19.60 | 19.66 | 0.30 | | 300784 | 利安科技 | 2.40 | 3.84 | 56.62 | 56.78 | 0.29 | | 600236 | 桂冠电力 | 0.32 | 0.05 | 6.32 | 6.34 | 0.28 | | 300076 | GQY视讯 | 1.71 | 1.47 | 6.54 | 6.56 | 0.25 | | 601898 | 中煤能源 | 0.97 | 0.11 | 11.42 | 11.45 | 0.24 | [1]

Core Viewpoint - The recent financial report of Kaikai Industrial (600272) shows a mixed performance with a significant increase in revenue but a sharp decline in net profit, indicating potential challenges in profitability and cash flow management [1][3]. Financial Performance Summary - Total revenue for the first half of 2025 reached 543 million yuan, a year-on-year increase of 10.95% compared to 490 million yuan in 2024 [1]. - Net profit attributable to shareholders was 11.8 million yuan, down 61.94% from 31.01 million yuan in the previous year [1]. - The gross margin decreased to 15.87%, down 15.89% year-on-year, while the net margin fell to 3.61%, a decline of 52.91% [1]. - The company reported a significant increase in accounts receivable, which rose by 36.84% to 565 million yuan [1]. Cash Flow and Financial Position - Cash flow from operating activities showed a remarkable increase of 471.56%, attributed to improved collection of receivables and increased sales in the SPD business [3][4]. - The company’s cash and cash equivalents increased by 21.51% to 190 million yuan, reflecting better cash management [1]. - The ratio of operating cash flow to current liabilities is concerning, averaging only 3.62% over the past three years [5]. Expense and Cost Management - Total selling, administrative, and financial expenses amounted to 65.93 million yuan, accounting for 12.14% of revenue, a decrease of 14.56% year-on-year [1]. - The company experienced a significant increase in financial expenses by 243.95%, primarily due to fluctuations in the USD exchange rate affecting receivables [3]. Business Model and Historical Performance - The company's return on invested capital (ROIC) was 7.29%, indicating average capital returns, with a historical median ROIC of 5.16% over the past decade [4]. - The business model relies heavily on marketing-driven strategies, which may require further analysis to understand underlying performance drivers [4].

据证券之星公开数据整理，近期开开实业（600272）发布2025年中报。截至本报告期末，公司营业总收 入5.43亿元，同比上升10.95%，归母净利润1180.1万元，同比下降61.94%。按单季度数据看，第二季度 营业总收入2.74亿元，同比上升7.2%，第二季度归母净利润382.25万元，同比下降50.67%。本报告期开 开实业应收账款上升，应收账款同比增幅达36.84%。 本次财报公布的各项数据指标表现一般。其中，毛利率15.87%，同比减15.89%，净利率3.61%，同比减 52.91%，销售费用、管理费用、财务费用总计6592.93万元，三费占营收比12.14%，同比减14.56%，每 股净资产2.55元，同比增0.82%，每股经营性现金流0.43元，同比增471.56%，每股收益0.05元，同比减 61.72% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 4.9亿 | 5.43 亿 | 10.95% 1 | | 归母净利润(元) | 3100.9万 | 1180.1万 | -61.94% | | ...

Core Viewpoint - The company has announced the investment of its idle funds into bank wealth management products, indicating a strategy to enhance returns on short-term capital [2] Group 1: Investment Details - The company will invest a total of 40 million RMB in structured deposits [2] - The investment has a term of 188 days [2] - The expected annualized return rates are 1.00%, 1.65%, or 1.75% [2]

Group 1 - The company reported a revenue of 543,143,362.01 yuan for the first half of 2025, representing a year-on-year growth of 10.95% [2] - The net profit attributable to shareholders of the listed company was 11,800,953.25 yuan, showing a year-on-year decline of 61.94% [2]

（文章来源：证券日报） 证券日报网讯 8月22日晚间，开开实业发布公告称，公司第十届监事会第十九次会议审议通过了《公司 2025年半年度报告及报告摘要》等。 ...

（文章来源：证券日报） 证券日报网讯 8月22日晚间，开开实业发布公告称，公司第十届董事会第二十八次会议审议通过了《公 司2025年半年度报告及报告摘要》等。 ...

Group 1 - The company held its 28th meeting of the 10th Board of Directors on August 21, 2025, with all 9 directors present, confirming compliance with relevant laws and regulations [1] - The meeting approved the 2025 semi-annual report and its summary, which had previously been reviewed by the Audit Committee [1] - The voting results for the semi-annual report were unanimous, with 9 votes in favor and no opposition or abstentions [1] Group 2 - The company proposed to reappoint the accounting firm for the 2025 financial statement audit and internal control audit, which was also approved by the Audit Committee [2] - This proposal will be submitted for review at the company's first extraordinary general meeting of 2025 [2] - The voting results for the reappointment proposal were also unanimous, with 9 votes in favor and no opposition or abstentions [2]